Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: SYNEDGEN, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2024-09-20 to 2026-10-08
Current total value of award: $2297415
Description: SBIR PHASE III PROPOSAL NO. JW230017 TITLED, "OPTIMIZED, FIELD-STABLE GLYCOPOLYMER-MIMICKING POLYSACCHARIDE TO PREVENT MORBIDITY AND MORTALITY IN EXPOSURE TO IONIZING RADIATION OR NUCLEAR INJURY"